FIELD: medicine.
SUBSTANCE: proposed is the use of hexapeptide Thr-Gly-Glu-Asn-His-Arg-NH2 as anxiolytic and anxiolytic new composition containing the active ingredient in the form of said hexapeptide (2-10 g/l) as a preservative nipagin (0.95-1.05 g/l), sodium chloride (10.0 g/l) and distilled water - the rest. Composition is highly effective in low doses, and easy to use: used in the form of nose drops. Proposed pharmaceutical composition can be used in clinical practice for correction of mental and neurological disorders.
EFFECT: anti-anxiety effect of the drug is comparable and in some characteristics superior to similar effect comparator drugs - diazepam (500 mcg/kg) and heptapeptide Selanc (300 mcg/kg).
2 cl, 7 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| PEPTIDE ELICITING ANTITUMOR, PROTECTIVE AND NORMALIZING ACTIVITY AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2213747C2 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BURN SKIN LESIONS | 2018 |
|
RU2704621C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| PEPTIDE ELICITING REGULATING BIOLOGICAL ACTIVITY OF PROTEIN SYNTHESIS IN HEPATOCYTES | 2002 |
|
RU2223113C1 |
| NOVEL GLYPROLINS WITH NOOTROPIC, ANTI-HYPOXIC, NEUROPROTECTIVE AND ANSSIYLITIS ACTIVITY | 2016 |
|
RU2646604C2 |
| USE OF PEPTIDE Gly-His-Lys FOR ANXIOLYTIC EFFECT | 2012 |
|
RU2480232C1 |
